Claudio Jommi

2.2k total citations
106 papers, 1.2k citations indexed

About

Claudio Jommi is a scholar working on Economics and Econometrics, Physiology and Immunology. According to data from OpenAlex, Claudio Jommi has authored 106 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Economics and Econometrics, 13 papers in Physiology and 12 papers in Immunology. Recurrent topics in Claudio Jommi's work include Health Systems, Economic Evaluations, Quality of Life (71 papers), Pharmaceutical Economics and Policy (58 papers) and Biosimilars and Bioanalytical Methods (11 papers). Claudio Jommi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (71 papers), Pharmaceutical Economics and Policy (58 papers) and Biosimilars and Bioanalytical Methods (11 papers). Claudio Jommi collaborates with scholars based in Italy, United Kingdom and France. Claudio Jommi's co-authors include Oriana Ciani, Patrizio Armeni, Marianna Cavazza, Arianna Bertolani, Francesco Costa, Giovanni Fattore, Aureliano Paolo Finch, Eugenio Anessi‐Pessina, Carla Rognoni and Pier Luigi Canonico and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Claudio Jommi

94 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Jommi Italy 20 684 171 151 109 106 106 1.2k
James D. Chambers United States 22 671 1.0× 205 1.2× 118 0.8× 63 0.6× 47 0.4× 90 1.2k
Wolf Rogowski Germany 20 480 0.7× 187 1.1× 142 0.9× 59 0.5× 75 0.7× 59 1.4k
Courtney Davis United Kingdom 19 742 1.1× 143 0.8× 177 1.2× 139 1.3× 50 0.5× 52 1.5k
Pengxiang Li United States 21 558 0.8× 209 1.2× 87 0.6× 62 0.6× 128 1.2× 70 1.4k
Ateesha F. Mohamed United States 23 540 0.8× 194 1.1× 200 1.3× 58 0.5× 77 0.7× 66 1.3k
Patricia A. Deverka United States 25 674 1.0× 394 2.3× 129 0.9× 82 0.8× 90 0.8× 62 2.0k
Guenka Petrova Bulgaria 19 579 0.8× 180 1.1× 43 0.3× 79 0.7× 93 0.9× 190 1.3k
Aaron Philip Mitchell United States 15 406 0.6× 116 0.7× 155 1.0× 51 0.5× 175 1.7× 64 1.3k
Anthony J. Hatswell United Kingdom 17 338 0.5× 80 0.5× 204 1.4× 51 0.5× 37 0.3× 65 826
Eline van Overbeeke Belgium 14 322 0.5× 151 0.9× 45 0.3× 57 0.5× 38 0.4× 26 674

Countries citing papers authored by Claudio Jommi

Since Specialization
Citations

This map shows the geographic impact of Claudio Jommi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Jommi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Jommi more than expected).

Fields of papers citing papers by Claudio Jommi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Jommi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Jommi. The network helps show where Claudio Jommi may publish in the future.

Co-authorship network of co-authors of Claudio Jommi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Jommi. A scholar is included among the top collaborators of Claudio Jommi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Jommi. Claudio Jommi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Severens, Johan L., et al.. (2025). Paving the road for a successful EU HTA Reform implementation. Global & Regional Health Technology Assessment. 12(1). 194–197.
2.
Marco, Fabiano Di, Arschang Valipour, Claudio Jommi, et al.. (2025). Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action. International Journal of COPD. Volume 20. 1595–1612.
3.
Falivena, Camilla, et al.. (2024). Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public. Journal of Patient-Reported Outcomes. 8(1). 36–36. 6 indexed citations
4.
Jommi, Claudio, et al.. (2024). Regional Formularies in Italy: current state and future perspectives. SHILAP Revista de lepidopterología. 11(1). 68–74. 1 indexed citations
5.
Jommi, Claudio, et al.. (2024). Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel. SHILAP Revista de lepidopterología. 11(1). 169–174.
6.
Jommi, Claudio, Michela Meregaglia, & Carmine Pinto. (2023). Unmet need: definitions, literature evidence and implications for HTA. SHILAP Revista de lepidopterología. 10. 70–78. 1 indexed citations
7.
Jommi, Claudio & Carlotta Galeone. (2023). The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency. PharmacoEconomics - Open. 7(3). 373–381. 8 indexed citations
8.
Tarantola, A., et al.. (2023). Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case. Journal of Pharmaceutical Policy and Practice. 16(1). 67–67. 12 indexed citations
9.
Canales, Miguel, Pier Luigi Canonico, Guillaume Cartron, et al.. (2023). Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries. Frontiers in Medicine. 10. 1128295–1128295. 12 indexed citations
10.
Drummond, Michael, Oriana Ciani, Claudio Jommi, et al.. (2023). How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?. BMC Health Services Research. 23(1). 484–484. 22 indexed citations
11.
Consoli, Agostino, Filippo de Braud, Massimo Riccaboni, et al.. (2022). Unmet clinical need e nuovi farmaci. Recenti Progressi in Medicina. 113(3). 161–166. 1 indexed citations
12.
Jommi, Claudio, et al.. (2022). Towards a More Competitive Italy in Clinical Research: The Survey of Attitudes towards Trial sites in Europe (The SAT-EU Study TM). SHILAP Revista de lepidopterología. 12(1). 2 indexed citations
13.
Jommi, Claudio, Patrizio Armeni, Francesco Costa, et al.. (2021). Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement). Recenti Progressi in Medicina. 112(11). 749–756. 2 indexed citations
14.
Finch, Aureliano Paolo, Michela Meregaglia, Oriana Ciani, Bram Roudijk, & Claudio Jommi. (2021). An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Social Science & Medicine. 292. 114519–114519. 57 indexed citations
15.
Chiumente, Marco, et al.. (2021). Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital. SHILAP Revista de lepidopterología. 8. 29–34. 4 indexed citations
16.
Galeone, Carlotta, Paolo Bruzzi, & Claudio Jommi. (2021). Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system. BMJ Open. 11(1). e041259–e041259. 14 indexed citations
17.
Jommi, Claudio, et al.. (2021). The future of Funds for Innovative Medicines: results from a Delphi Study. SHILAP Revista de lepidopterología. 8. 22–28. 5 indexed citations
18.
Jommi, Claudio & Arianna Bertolani. (2020). PBI35 Local Policies on Biosimilars: Are They Designed to Optimize Use of Freed Resources?. Value in Health. 23. S416–S416. 1 indexed citations
19.
Jommi, Claudio, Giovanni Apolone, Americo Cicchetti, et al.. (2019). Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti. 20(4). 168–179. 2 indexed citations
20.
Cozzolino, Mario, Piergiorgio Bolasco, Claudio Ronco, et al.. (2018). Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study. ˜The œNephron journals/Nephron journals. 140(1). 39–47. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James D. Chambers Breakdown of academic impact, for papers by Wolf Rogowski Breakdown of academic impact, for papers by Courtney Davis Breakdown of academic impact, for papers by Pengxiang Li Breakdown of academic impact, for papers by Ateesha F. Mohamed Breakdown of academic impact, for papers by Patricia A. Deverka Breakdown of academic impact, for papers by Guenka Petrova Breakdown of academic impact, for papers by Aaron Philip Mitchell Breakdown of academic impact, for papers by Anthony J. Hatswell Breakdown of academic impact, for papers by Eline van Overbeeke
Rankless by CCL
2026